The Alfred hospital in Melbourne has embarked on a ground-breaking journey to revolutionize brain health management with the help of BrainEye, a cutting-edge smartphone app.
This innovative technology utilizes a 60-second eye movement test to screen for neurological abnormalities, for early detection and monitoring of conditions like Alzheimer’s, Parkinson’s disease, epilepsy, and multiple sclerosis.
The app, currently in clinical trials with 500 participants across Australia, collects data through its AI platform, comparing more than 20 ocular biomarkers to enhance its understanding of normal and abnormal brain function.
This development could lead to a cost-effective and accessible tool for detecting and monitoring neuro- degenerative diseases.
Get more info on the Alfred Hospital website.
